Cell Line Development Market to 2027 - Global Analysis and Forecasts By Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bio production and Tissue Engineering); and Geography
- THE3479205
- 165 Pages
- January 2020
- Diagnostic and Biotech
Driving factors are increasing the adoption of regenerative medicines, rising prevalence of cancer across the globe, and increasing investments in R&D by pharmaceutical and biotechnology companies. However, risks associated with cell line contamination is expected to hamper the market during the forecast period.
The cell line is established cell culture, which gets increased numerous times when supplied with the growth medium and space for growth. Different cell lines can be made from different cells. The cell line plays a vital role in the study of cytology. The cell line enables stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment.
The global cell line development market is bifurcated into type, product, and application. Based on type, the cell line development market is segmented into a primary cell line, hybridomas, continuous cell lines, and recombinant cell line. Based on product, the cell line development market is segmented into equipment, media and reagent. On the basis of application, the cell line development market is bifurcated into drug discovery, bioproduction, and tissue engineering. In 2018, the bioproduction segment held the largest share of the market. However, the drug discovery segment is expected to register the highest CAGR in the market during the forecast period.
Some of the essential primary and secondary sources included in the report are the Food and Drug Administration (FDA), World Health Organization (WHO), American Cancer Society, National Institute of Cancer Prevention and Research (NICPR), Deutsche Forschungsgemeinschaft (DFG), Defense Advanced Research Projects Agency (DARPA), Centers for Disease Control and Prevention, and others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Cell Line Development Market - By Type
1.3.2 Global Cell Line Development Market - By Product
1.3.3 Global Cell Line Development Market - By Application
1.3.4 Global Cell Line Development Market - By Geography
2. Cell Line Development Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Cell Line Development - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cell Line Development Market in North America: PEST Analysis
4.2.2 Cell Line Development Market in Europe: PEST Analysis
4.2.3 Cell line development Market in APAC: PEST Analysis
4.2.4 Cell Line Development Market in MEA: PEST Analysis
4.2.5 Cell Line Development Market - South and Central America PEST Analysis
4.3 Expert Opinion
5. Global Cell Line Development Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Regenerative Medicines
5.1.2 Rising Prevalence of Cancer
5.1.3 Growing Investment in R&D by Pharmaceutical and Biotechnology Companies
5.2 Key Restraints
5.2.1 Risk Associated with Cell Line Contamination
5.3 Key Opportunity
5.3.1 Middle Income Countries Creating Development Opportunities
5.4 Future Trend
5.4.1 Consistent Research in Drug Discovery Activities
5.5 Impact Analysis
6. Cell Line Development Market - Global Analysis
6.1 Global Cell Line Development Market Revenue Forecast and Analysis
6.2 Global Cell Line Development Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.3.1 Merck KGaA
6.3.2 Thermo Fisher Scientific Inc.
7. Cell Line Development Market - Revenue and Forecasts to 2027 - Type
7.1 Overview
7.2 Global Cell Line Development Market, by Type, 2018 & 2027 (% Share)
7.3 Primary Cell Line
7.3.1 Overview
7.3.2 Global Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Hybridomas
7.4.1 Overview
7.4.2 Global Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Continuous Cell Lines
7.5.1 Overview
7.5.2 Global Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Recombinant Cell Line
7.6.1 Overview
7.6.2 Global Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
8. Cell Line Development Market Analysis and Forecasts to 2027 - Product
8.1 Overview
8.2 Global Cell Line Development Market, by Product, 2018 & 2027 (% Share)
8.3 Equipment
8.3.1 Overview
8.3.2 Global Equipment Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Media and Reagent
8.4.1 Overview
8.4.2 Global Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)
9. Cell Line Development Market Analysis and Forecasts to 2027 - Application
9.1 Overview
9.2 Global Cell Line Development Market Share by Application 2018 & 2027 (%)
9.3 Drug Discovery
9.3.1 Overview
9.3.2 Global Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Bioproduction
9.4.1 Overview
9.4.2 Global Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Tissue Engineering
9.5.1 Overview
9.5.2 Global Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
10. Cell Line Development Market Revenue and Forecast to 2027 - Geographical Analysis
10.1 North America Cell Line Development Market, Revenue and Forecast to2027
10.1.1 Overview
10.1.2 North America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.3 North America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.4 North America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.5 North America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.6 North America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.1.7 US
10.1.7.1 US Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.7.2 US Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.7.3 US Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.7.4 US Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.8 Canada
10.1.8.1 Canada Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.8.2 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.8.3 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.8.4 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.9 Mexico
10.1.9.1 Mexico Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.9.2 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.9.3 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.9.4 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2 Europe Cell Line Development Market Revenue and Forecast to 2027
10.2.1 Europe Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.2 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.3 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.4 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.5 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.2.6 Germany
10.2.6.1 Germany Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.6.2 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.6.3 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.6.4 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.7 UK
10.2.7.1 UK Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.7.2 UK Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.7.3 UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.7.4 UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.8 France
10.2.8.1 France Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.8.2 France Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.8.3 France Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.8.4 France Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.9 Spain
10.2.9.1 Spain Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.9.2 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.9.3 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.9.4 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.10 Italy
10.2.10.1 Italy Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.10.2 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.10.3 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.10.4 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3 APAC Cell Line Development Market, Revenue and Forecast to 2027
10.3.1 Overview
10.3.2 APAC Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.3 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.4 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.5 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.6 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.3.7 China
10.3.7.1 China Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.7.2 China Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.7.3 China Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.7.4 China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.8 Japan
10.3.8.1 Japan Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.8.2 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.8.3 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.8.4 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.9 India
10.3.9.1 India Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.9.2 India Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.9.3 India Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.9.4 India Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.10 South Korea
10.3.10.1 South Korea Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.10.2 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.10.3 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.10.4 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.11 Australia
10.3.11.1 Australia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.11.2 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.11.3 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.11.4 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.4 MEA Cell Line Development Market, Revenue and Forecast to 2027
10.4.1 Overview
10.4.2 MEA Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.3 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.4.4 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.4.5 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.4.6 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.4.7 UAE
10.4.7.1 UAE Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.7.2 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.4.7.3 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.4.7.4 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.4.8 Saudi Arabia
10.4.8.1 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.8.2 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.4.8.3 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.4.8.4 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.4.9 South Africa
10.4.9.1 South Africa Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.9.2 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.4.9.3 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.4.9.4 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.5 South and Central America Cell Line Development Market, Revenue and Forecast to 2027
10.5.1 Overview
10.5.2 South and Central America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.5.3 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.5.4 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.5.5 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.5.6 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.5.7 Brazil
10.5.7.1 Brazil Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.5.7.2 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.5.7.3 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.5.7.4 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.5.8 Argentina
10.5.8.1 Argentina Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.5.8.2 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.5.8.3 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.5.8.4 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
11. Cell Line Development Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in The Market, (%)
11.3 Organic Developments Done by The Companies in the Market
11.4 Inorganic Developments Done by The Companies in the Market
12. Cell Line Development Market- Key Company Profiles
12.1 Merck KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Thermo Fisher Scientific, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Information
12.2.4 Product /Services Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 SELEXIS
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product/Service Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BioFactura, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 WuXi AppTec
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Service Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 LakePharma, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 General Electric
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Lonza
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Information
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Corning Incorporated
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
